ABBVIE INC (4AB.DE) Fundamental Analysis & Valuation
FRA:4AB • US00287Y1091
Current stock price
171.9 EUR
-1.45 (-0.84%)
Last:
This 4AB.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 4AB.DE Profitability Analysis
1.1 Basic Checks
- 4AB had positive earnings in the past year.
- 4AB had a positive operating cash flow in the past year.
- 4AB had positive earnings in each of the past 5 years.
- In the past 5 years 4AB always reported a positive cash flow from operatings.
1.2 Ratios
- 4AB's Return On Assets of 3.12% is fine compared to the rest of the industry. 4AB outperforms 75.31% of its industry peers.
- The Return On Invested Capital of 4AB (14.42%) is better than 90.12% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for 4AB is in line with the industry average of 12.00%.
- The last Return On Invested Capital (14.42%) for 4AB is above the 3 year average (12.12%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROIC | 14.42% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
1.3 Margins
- 4AB's Profit Margin of 6.84% is fine compared to the rest of the industry. 4AB outperforms 75.31% of its industry peers.
- In the last couple of years the Profit Margin of 4AB has declined.
- Looking at the Operating Margin, with a value of 34.23%, 4AB belongs to the top of the industry, outperforming 90.12% of the companies in the same industry.
- 4AB's Operating Margin has improved in the last couple of years.
- 4AB has a better Gross Margin (71.62%) than 62.96% of its industry peers.
- 4AB's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% |
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
2. 4AB.DE Health Analysis
2.1 Basic Checks
- 4AB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- 4AB has about the same amout of shares outstanding than it did 1 year ago.
- Compared to 5 years ago, 4AB has about the same amount of shares outstanding.
- 4AB has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.24 indicates that 4AB is not a great score, but indicates only limited risk for bankruptcy at the moment.
- 4AB has a Altman-Z score of 2.24. This is comparable to the rest of the industry: 4AB outperforms 56.79% of its industry peers.
- The Debt to FCF ratio of 4AB is 3.79, which is a good value as it means it would take 4AB, 3.79 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of 4AB (3.79) is better than 83.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Altman-Z | 2.24 |
ROIC/WACC1.61
WACC8.95%
2.3 Liquidity
- 4AB has a Current Ratio of 0.67. This is a bad value and indicates that 4AB is not financially healthy enough and could expect problems in meeting its short term obligations.
- 4AB's Current ratio of 0.67 is on the low side compared to the rest of the industry. 4AB is outperformed by 83.95% of its industry peers.
- 4AB has a Quick Ratio of 0.67. This is a bad value and indicates that 4AB is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of 4AB (0.56) is worse than 82.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 |
3. 4AB.DE Growth Analysis
3.1 Past
- The earnings per share for 4AB have decreased by -1.19% in the last year.
- 4AB shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.99% yearly.
- The Revenue has grown by 8.57% in the past year. This is quite good.
- 4AB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.95% yearly.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
3.2 Future
- The Earnings Per Share is expected to grow by 15.08% on average over the next years. This is quite good.
- Based on estimates for the next years, 4AB will show a small growth in Revenue. The Revenue will grow by 6.43% on average per year.
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue Next Year10.03%
Revenue Next 2Y9.07%
Revenue Next 3Y8.45%
Revenue Next 5Y6.43%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. 4AB.DE Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 20.11, 4AB is valued on the expensive side.
- 82.72% of the companies in the same industry are more expensive than 4AB, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 27.47, 4AB is valued a bit cheaper.
- 4AB is valuated correctly with a Price/Forward Earnings ratio of 13.56.
- Based on the Price/Forward Earnings ratio, 4AB is valued cheaper than 95.06% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of 4AB to the average of the S&P500 Index (22.62), we can say 4AB is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.11 | ||
| Fwd PE | 13.56 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 4AB is valued cheaply inside the industry as 82.72% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, 4AB is valued cheaper than 91.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.96 | ||
| EV/EBITDA | 14.28 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- 4AB has a very decent profitability rating, which may justify a higher PE ratio.
- 4AB's earnings are expected to grow with 22.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y28.1%
EPS Next 3Y22.01%
5. 4AB.DE Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 3.31%, 4AB has a reasonable but not impressive dividend return.
- 4AB's Dividend Yield is rather good when compared to the industry average which is at 0.63. 4AB pays more dividend than 97.53% of the companies in the same industry.
- 4AB's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.31% |
5.2 History
- The dividend of 4AB is nicely growing with an annual growth rate of 6.76%!
Dividend Growth(5Y)6.76%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
- 4AB pays out 278.48% of its income as dividend. This is not a sustainable payout ratio.
- 4AB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP278.48%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
4AB.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:4AB (4/23/2026, 7:00:00 PM)
171.9
-1.45 (-0.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)04-29 2026-04-29/bmo
Inst Owners76.21%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap304.05B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.95
Price Target217.08 (26.28%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.31% |
Yearly Dividend5.59
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)0.23%
PT rev (3m)1.88%
EPS NQ rev (1m)-9.13%
EPS NQ rev (3m)-11.91%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.35%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.11 | ||
| Fwd PE | 13.56 | ||
| P/S | 5.81 | ||
| P/FCF | 19.96 | ||
| P/OCF | 18.68 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.28 |
EPS(TTM)8.55
EY4.97%
EPS(NY)12.68
Fwd EY7.38%
FCF(TTM)8.61
FCFY5.01%
OCF(TTM)9.2
OCFY5.35%
SpS29.57
BVpS-1.58
TBVpS-44.26
PEG (NY)0.42
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROCE | 23.09% | ||
| ROIC | 14.42% | ||
| ROICexc | 15.28% | ||
| ROICexgc | N/A | ||
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% | ||
| FCFM | 29.13% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Debt/EBITDA | 2.11 | ||
| Cap/Depr | 14.92% | ||
| Cap/Sales | 1.98% | ||
| Interest Coverage | 6.97 | ||
| Cash Conversion | 65.45% | ||
| Profit Quality | 425.61% | ||
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 2.24 |
F-Score8
WACC8.95%
ROIC/WACC1.61
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.03%
Revenue Next 2Y9.07%
Revenue Next 3Y8.45%
Revenue Next 5Y6.43%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.08%
EBIT Next 3Y19.31%
EBIT Next 5Y10.21%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%
ABBVIE INC / 4AB.DE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of ABBVIE INC (4AB.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to 4AB.DE.
What is the valuation status for 4AB stock?
ChartMill assigns a valuation rating of 8 / 10 to ABBVIE INC (4AB.DE). This can be considered as Undervalued.
Can you provide the profitability details for ABBVIE INC?
ABBVIE INC (4AB.DE) has a profitability rating of 7 / 10.
How financially healthy is ABBVIE INC?
The financial health rating of ABBVIE INC (4AB.DE) is 3 / 10.
What is the earnings growth outlook for ABBVIE INC?
The Earnings per Share (EPS) of ABBVIE INC (4AB.DE) is expected to grow by 48.29% in the next year.